Premium
Health insurance and payment systems for severe acute pancreatitis
Author(s) -
Yoshida Masahiro,
Takada Tadahiro,
Hirata Koichi,
Mayumi Toshihiko,
Shikata Satoru,
Shirai Kunihiro,
Kimura Yasutoshi,
Wada Keita,
Amano Hodaka,
Arata Shinju,
Hirota Masahiko,
Takeda Kazunori,
Gabata Toshifumi,
Hirota Morihisa,
Yokoe Masamichi,
Kiriyama Seiki,
Sekimoto Miho
Publication year - 2010
Publication title -
journal of hepato‐biliary‐pancreatic sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.63
H-Index - 60
eISSN - 1868-6982
pISSN - 1868-6974
DOI - 10.1007/s00534-009-0215-2
Subject(s) - business , government (linguistics) , health care , self insurance , medical underwriting , actuarial science , social security , group insurance , payment , income protection insurance , insurance policy , health policy , general insurance , finance , economic growth , economics , market economy , philosophy , linguistics
The medical insurance system of Japan is based on the Universal Medical Care System guaranteed by the provision of the Article 25 of the Constitution of Japan, which states that “All the people shall have the right to live a healthy, cultural and minimum standard of life.” The health insurance system of Japan comprises the medical insurance system and the health care system for the long‐lived. Medical care insurance includes the employees’ health insurance (Social Insurance) that covers employees of private companies and their families and community insurance (National Health Insurance) that covers the self‐employed. Each medical insurance system has its own medical care system for the retired and their families. The health care system for the long‐lived covers people of over 75 years of age (over 65 years in people with a certain handicap). There is also a system under which all or part of the medical expenses is reimbursed by public expenditure or the cost of medical care not covered by health insurance is paid by the government. This system is referred to collectively as the “the public payment system of medical expenses.” To support the realization of the purpose of this system, there is a treatment research enterprise for specified diseases (intractable diseases). Because of the high mortality rate, acute pancreatitis is specified as an intractable disease for the purpose of reducing its mortality rate, and treatment expenses of patients are paid in full by the government dating back to the day when the application was made for a certificate verifying that he or she has severe acute pancreatitis.